News – Page 59 – Endpoints News

Dyne details pivotal plans for myotonic dystrophy RNA drug, though data blip worries some investors

4 months ago

AbbVie writes off $3.5B on Cerevel drug after Phase 2 failures

4 months ago

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

4 months ago

The new China dynamic, Trump 2.0, markets and more: See you tomorrow at JPM!

4 months ago

Stemson Therapeutics shutters; Insilico teams up again with Menarini

4 months ago

City Therapeutics, Bausch + Lomb partner on preclinical RNAi eye drug

4 months ago

Four biotechs emerge with $800M and in-licensed assets on Friday

4 months ago

Updated: CDER Director Patrizia Cavazzoni to step down ahead of Trump presidency

4 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

4 months ago

John Maraganore turns to ex-Alnylam colleague to lead his latest RNAi bet; Amylyx names commercial chief

4 months ago

Lilly ventures into pulmonary fibrosis with startup Mediar

4 months ago

Repare pauses late-stage plans, reshuffles pipeline in effort to cut costs

4 months ago

Marea reports early Phase 2 data for cholesterol-lowering drug it licensed from Novartis

4 months ago

With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ring

4 months ago

Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027

4 months ago

Shoreline cuts staff as its partnership with Gilead's Kite is now in flux

4 months ago

IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint

4 months ago

Bayer says elinzanetant quelled hot flashes in women undergoing cancer treatment

4 months ago

Catalyst staves off Firdapse competition from Teva for a decade

4 months ago

Tenpoint reveals positive Phase 3 data for vision drug after Visus merger

4 months ago

Cell therapy startup A2 Biotherapeutics nets $80M Series C

4 months ago

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

4 months ago

Is this the digital health M&A wave we’ve been expecting?

4 months ago

Samsung Bio extends ADC partnership; Veeda rebrands as CDMO

4 months ago

First page Previous page 56 57 585960 61 62 Next page Last page